3 years of experience in disease modelling and pre-clinical drug screening using Drosophila and Rat models. She possesses strong expertise in the field of cancer genetics, immunology and host-tumor inter-organ crosstalk with extensive hands on of confocal microscopy and histology techniques. At Mestastop, she will be conducting drug screenings for compound (s) displaying suppression or delay in metastasis for its therapeutics.